Literature DB >> 32808054

Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T.

Yoshiki Mori1, Yasumi Nakashima2, Sachie Kaneko2, Nao Inoue2, Tomotaka Murakami2.   

Abstract

Few reports have described the prognostic value of measuring both B-type natriuretic peptides (BNP) and high-sensitivity troponin T (hs-TnT) in pediatric patients with complex congenital heart disease (CHD) undergoing surgery. We assessed demographic, hemodynamic, and laboratory data, including BNP and hs-TnT levels, for the prediction of cardiac adverse events in 85 patients. Cardiac adverse events were defined as death, cardiac arrest, worsening heart failure requiring inotropic agents and/or respiratory support, and unscheduled surgery/intervention either within or after 12 months of surgery. There were 17 cardiac adverse events. Of the demographic variables, low birth weight (< 2500 g: Odds ratio [OR], 5.97; 95% confidential interval [CI] 1.48-24.0; p = 0.001) and Ross/New York Heart Association [NYHA] class (≥ 2.0) (OR 12.7; 95% CI 3.08-52.7; p = 0.0004) were strongly association with cardiac adverse events. Among hemodynamic and laboratory variables, preoperative BNP (OR 14.04; 95% CI 2.15-91.7; p = 0.001) and hs-TnT levels (OR 16.66; 95% CI 2.27-122; p = 0.002) were found to be independent risk factors. Receiver operating characteristic analysis determined BNP and hs-TnT levels of 60.9 pg/mL and 0.025 ng/mL, respectively, to be markers of high risk. Kaplan-Meier analysis demonstrated significant differences in the freedom from cardiac adverse events between Group A (BNP or hs-TnT elevated, n = 26) and Group B (both biomarkers elevated, n = 19; log-rank, p < 0.001). In conclusion, low birth weight (< 2500 g) and Ross/NYHA class ≥ 2.0 are strongly associated with cardiac adverse events. Preoperative BNP and hs-TnT also provide prognostic information in patients with complex CHD scheduled for surgery. Using both markers in combination predicts cardiac adverse events better than using either separately.

Entities:  

Keywords:  Complex congenital heart disease; Natriuretic peptides; Pediatric cardiac surgery; Risk stratification; Troponin

Year:  2020        PMID: 32808054     DOI: 10.1007/s00246-020-02437-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  34 in total

Review 1.  Biomarkers in heart failure.

Authors:  Eugene Braunwald
Journal:  N Engl J Med       Date:  2008-05-15       Impact factor: 91.245

2.  Risk factors for deaths occurring within 30 days and 1 year after hospital discharge for cardiac surgery among pediatric patients.

Authors:  Ruey-Kang R Chang; Sandra Rodriguez; Maggie Lee; Thomas S Klitzner
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

3.  Troponin-I for prediction of early postoperative course after pediatric cardiac surgery.

Authors:  F F Immer; F Stocker; A M Seiler; J P Pfammatter; D Bachmann; G Printzen; T Carrel
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

Review 4.  Consensus-based method for risk adjustment for surgery for congenital heart disease.

Authors:  Kathy J Jenkins; Kimberlee Gauvreau; Jane W Newburger; Thomas L Spray; James H Moller; Lisa I Iezzoni
Journal:  J Thorac Cardiovasc Surg       Date:  2002-01       Impact factor: 5.209

5.  Risk factors associated with readmission after pediatric cardiothoracic surgery.

Authors:  Brian Kogon; Ashish Jain; Matthew Oster; Kimberly Woodall; Kirk Kanter; Paul Kirshbom
Journal:  Ann Thorac Surg       Date:  2012-06-08       Impact factor: 4.330

Review 6.  Unexpected deaths and unplanned re-admissions in infants discharged home after cardiac surgery: a systematic review of potential risk factors.

Authors:  Jenifer Tregay; Jo Wray; Catherine Bull; Rodney C Franklin; Piers Daubeney; David J Barron; Katherine Brown; Rachel L Knowles
Journal:  Cardiol Young       Date:  2014-12-30       Impact factor: 1.093

7.  Female sex as a risk factor for in-hospital mortality among children undergoing cardiac surgery.

Authors:  Ruey-Kang R Chang; Alex Y Chen; Thomas S Klitzner
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

8.  Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications.

Authors:  Giovanna A L Lurati Buse; Daniel Bolliger; Esther Seeberger; Jorge Kasper; Martin Grapow; Michael T Koller; Manfred D Seeberger; Miodrag Filipovic
Journal:  Circulation       Date:  2014-08-06       Impact factor: 29.690

9.  Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I.

Authors:  Fabio Carmona; Paulo H Manso; Walter V A Vicente; Margaret Castro; Ana P C P Carlotti
Journal:  Cytokine       Date:  2008-04-15       Impact factor: 3.861

10.  Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker.

Authors:  Chie-Youn Shih; Anil Sapru; Peter Oishi; Anthony Azakie; Tom R Karl; Cynthia Harmon; Ritu Asija; Ian Adatia; Jeffrey R Fineman
Journal:  J Thorac Cardiovasc Surg       Date:  2006-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.